| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Roles of amyloid beta-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment.
|
Free Radic Biol Med
|
2007
|
2.08
|
|
2
|
Oxidative stress in Alzheimer's disease brain: new insights from redox proteomics.
|
Eur J Pharmacol
|
2006
|
1.57
|
|
3
|
Biliverdin reductase-A: a novel drug target for atorvastatin in a dog pre-clinical model of Alzheimer disease.
|
J Neurochem
|
2011
|
1.53
|
|
4
|
Controlled enzymatic production of astrocytic hydrogen peroxide protects neurons from oxidative stress via an Nrf2-independent pathway.
|
Proc Natl Acad Sci U S A
|
2010
|
1.45
|
|
5
|
Redox proteomics identification of oxidatively modified brain proteins in Alzheimer's disease and mild cognitive impairment: insights into the progression of this dementing disorder.
|
J Alzheimers Dis
|
2007
|
1.40
|
|
6
|
Redox proteomic identification of 4-hydroxy-2-nonenal-modified brain proteins in amnestic mild cognitive impairment: insight into the role of lipid peroxidation in the progression and pathogenesis of Alzheimer's disease.
|
Neurobiol Dis
|
2008
|
1.38
|
|
7
|
Involvements of the lipid peroxidation product, HNE, in the pathogenesis and progression of Alzheimer's disease.
|
Biochim Biophys Acta
|
2010
|
1.38
|
|
8
|
Elevated protein-bound levels of the lipid peroxidation product, 4-hydroxy-2-nonenal, in brain from persons with mild cognitive impairment.
|
Neurosci Lett
|
2006
|
1.38
|
|
9
|
Lipopolysaccharide alters the blood-brain barrier transport of amyloid beta protein: a mechanism for inflammation in the progression of Alzheimer's disease.
|
Brain Behav Immun
|
2009
|
1.32
|
|
10
|
Proteomic identification of oxidized mitochondrial proteins following experimental traumatic brain injury.
|
J Neurotrauma
|
2007
|
1.30
|
|
11
|
Redox proteomics in selected neurodegenerative disorders: from its infancy to future applications.
|
Antioxid Redox Signal
|
2012
|
1.24
|
|
12
|
An increase in S-glutathionylated proteins in the Alzheimer's disease inferior parietal lobule, a proteomics approach.
|
J Neurosci Res
|
2007
|
1.23
|
|
13
|
Adriamycin-induced, TNF-alpha-mediated central nervous system toxicity.
|
Neurobiol Dis
|
2006
|
1.22
|
|
14
|
Elevated levels of 3-nitrotyrosine in brain from subjects with amnestic mild cognitive impairment: implications for the role of nitration in the progression of Alzheimer's disease.
|
Brain Res
|
2007
|
1.21
|
|
15
|
Amyloid β-peptide (1-42)-induced oxidative stress in Alzheimer disease: importance in disease pathogenesis and progression.
|
Antioxid Redox Signal
|
2013
|
1.20
|
|
16
|
In vivo oxidative stress in brain of Alzheimer disease transgenic mice: Requirement for methionine 35 in amyloid beta-peptide of APP.
|
Free Radic Biol Med
|
2009
|
1.20
|
|
17
|
Nitrosative stress, cellular stress response, and thiol homeostasis in patients with Alzheimer's disease.
|
Antioxid Redox Signal
|
2006
|
1.20
|
|
18
|
Pin1 in Alzheimer's disease.
|
J Neurochem
|
2006
|
1.16
|
|
19
|
Free radical mediated oxidative stress and toxic side effects in brain induced by the anti cancer drug adriamycin: insight into chemobrain.
|
Free Radic Res
|
2005
|
1.10
|
|
20
|
Redox proteomics identification of 4-hydroxynonenal-modified brain proteins in Alzheimer's disease: Role of lipid peroxidation in Alzheimer's disease pathogenesis.
|
Proteomics Clin Appl
|
2009
|
1.08
|
|
21
|
Adriamycin-mediated nitration of manganese superoxide dismutase in the central nervous system: insight into the mechanism of chemobrain.
|
J Neurochem
|
2007
|
1.08
|
|
22
|
Proteomic identification of proteins oxidized by Abeta(1-42) in synaptosomes: implications for Alzheimer's disease.
|
Brain Res
|
2005
|
1.06
|
|
23
|
HIV-dementia, Tat-induced oxidative stress, and antioxidant therapeutic considerations.
|
Brain Res Brain Res Rev
|
2005
|
1.05
|
|
24
|
Protein levels of heat shock proteins 27, 32, 60, 70, 90 and thioredoxin-1 in amnestic mild cognitive impairment: an investigation on the role of cellular stress response in the progression of Alzheimer disease.
|
Brain Res
|
2010
|
1.05
|
|
25
|
Antisense directed at the Abeta region of APP decreases brain oxidative markers in aged senescence accelerated mice.
|
Brain Res
|
2004
|
1.04
|
|
26
|
Alumina nanoparticles induce expression of endothelial cell adhesion molecules.
|
Toxicol Lett
|
2008
|
1.03
|
|
27
|
Elevated levels of pro-apoptotic p53 and its oxidative modification by the lipid peroxidation product, HNE, in brain from subjects with amnestic mild cognitive impairment and Alzheimer's disease.
|
J Cell Mol Med
|
2008
|
1.03
|
|
28
|
Chemo brain (chemo fog) as a potential side effect of doxorubicin administration: role of cytokine-induced, oxidative/nitrosative stress in cognitive dysfunction.
|
Adv Exp Med Biol
|
2010
|
1.02
|
|
29
|
Oxidative damage in brain from human mutant APP/PS-1 double knock-in mice as a function of age.
|
Free Radic Biol Med
|
2008
|
1.02
|
|
30
|
Ethyl ferulate, a lipophilic polyphenol, induces HO-1 and protects rat neurons against oxidative stress.
|
Antioxid Redox Signal
|
2004
|
1.02
|
|
31
|
Loss of phospholipid asymmetry and elevated brain apoptotic protein levels in subjects with amnestic mild cognitive impairment and Alzheimer disease.
|
Neurobiol Dis
|
2007
|
1.01
|
|
32
|
Quantitative proteomics analysis of phosphorylated proteins in the hippocampus of Alzheimer's disease subjects.
|
J Proteomics
|
2011
|
1.01
|
|
33
|
Glutathione elevation by gamma-glutamyl cysteine ethyl ester as a potential therapeutic strategy for preventing oxidative stress in brain mediated by in vivo administration of adriamycin: Implication for chemobrain.
|
J Neurosci Res
|
2007
|
1.00
|
|
34
|
In vivo administration of D609 leads to protection of subsequently isolated gerbil brain mitochondria subjected to in vitro oxidative stress induced by amyloid beta-peptide and other oxidative stressors: relevance to Alzheimer's disease and other oxidative stress-related neurodegenerative disorders.
|
Free Radic Biol Med
|
2006
|
1.00
|
|
35
|
2-Mercaptoethane sulfonate prevents doxorubicin-induced plasma protein oxidation and TNF-α release: implications for the reactive oxygen species-mediated mechanisms of chemobrain.
|
Free Radic Biol Med
|
2011
|
1.00
|
|
36
|
Mutations in amyloid precursor protein and presenilin-1 genes increase the basal oxidative stress in murine neuronal cells and lead to increased sensitivity to oxidative stress mediated by amyloid beta-peptide (1-42), HO and kainic acid: implications for Alzheimer's disease.
|
J Neurochem
|
2006
|
0.99
|
|
37
|
Alteration of hepatic structure and oxidative stress induced by intravenous nanoceria.
|
Toxicol Appl Pharmacol
|
2012
|
0.98
|
|
38
|
Roles of 3-nitrotyrosine- and 4-hydroxynonenal-modified brain proteins in the progression and pathogenesis of Alzheimer's disease.
|
Free Radic Res
|
2010
|
0.98
|
|
39
|
In vivo protection of synaptosomes by ferulic acid ethyl ester (FAEE) from oxidative stress mediated by 2,2-azobis(2-amidino-propane)dihydrochloride (AAPH) or Fe(2+)/H(2)O(2): insight into mechanisms of neuroprotection and relevance to oxidative stress-related neurodegenerative disorders.
|
Neurochem Int
|
2005
|
0.98
|
|
40
|
Proteomics-determined differences in the concanavalin-A-fractionated proteome of hippocampus and inferior parietal lobule in subjects with Alzheimer's disease and mild cognitive impairment: implications for progression of AD.
|
J Proteome Res
|
2009
|
0.96
|
|
41
|
Rodent Abeta(1-42) exhibits oxidative stress properties similar to those of human Abeta(1-42): Implications for proposed mechanisms of toxicity.
|
J Alzheimers Dis
|
2004
|
0.96
|
|
42
|
Atorvastatin treatment in a dog preclinical model of Alzheimer's disease leads to up-regulation of haem oxygenase-1 and is associated with reduced oxidative stress in brain.
|
Int J Neuropsychopharmacol
|
2011
|
0.96
|
|
43
|
Role of phenylalanine 20 in Alzheimer's amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity.
|
Chem Res Toxicol
|
2004
|
0.95
|
|
44
|
Brain distribution and toxicological evaluation of a systemically delivered engineered nanoscale ceria.
|
Toxicol Sci
|
2010
|
0.95
|
|
45
|
Oxidative modification to LDL receptor-related protein 1 in hippocampus from subjects with Alzheimer disease: implications for Aβ accumulation in AD brain.
|
Free Radic Biol Med
|
2010
|
0.95
|
|
46
|
Opening Pandora's jar: a primer on the putative roles of CRMP2 in a panoply of neurodegenerative, sensory and motor neuron, and central disorders.
|
Future Neurol
|
2012
|
0.95
|
|
47
|
Heme oxygenase-1 posttranslational modifications in the brain of subjects with Alzheimer disease and mild cognitive impairment.
|
Free Radic Biol Med
|
2012
|
0.95
|
|
48
|
Identification of 3-nitrotyrosine-modified brain proteins by redox proteomics.
|
Methods Enzymol
|
2008
|
0.94
|
|
49
|
Effects of oxidative and nitrosative stress in brain on p53 proapoptotic protein in amnestic mild cognitive impairment and Alzheimer disease.
|
Free Radic Biol Med
|
2008
|
0.93
|
|
50
|
Oxidative and nitrosative modifications of biliverdin reductase-A in the brain of subjects with Alzheimer's disease and amnestic mild cognitive impairment.
|
J Alzheimers Dis
|
2011
|
0.93
|
|
51
|
Increase in Mrp1 expression and 4-hydroxy-2-nonenal adduction in heart tissue of Adriamycin-treated C57BL/6 mice.
|
Mol Cancer Ther
|
2006
|
0.93
|
|
52
|
In vivo protective effects of ferulic acid ethyl ester against amyloid-beta peptide 1-42-induced oxidative stress.
|
J Neurosci Res
|
2006
|
0.92
|
|
53
|
Distribution, elimination, and biopersistence to 90 days of a systemically introduced 30 nm ceria-engineered nanomaterial in rats.
|
Toxicol Sci
|
2012
|
0.91
|
|
54
|
Glutathionylation of the pro-apoptotic protein p53 in Alzheimer's disease brain: implications for AD pathogenesis.
|
Neurochem Res
|
2009
|
0.91
|
|
55
|
Oxidative modification of lipoic acid by HNE in Alzheimer disease brain.
|
Redox Biol
|
2013
|
0.91
|
|
56
|
Biliverdin reductase--a protein levels and activity in the brains of subjects with Alzheimer disease and mild cognitive impairment.
|
Biochim Biophys Acta
|
2011
|
0.90
|
|
57
|
Oxidative stress and toxicity induced by the nucleoside reverse transcriptase inhibitor (NRTI)--2',3'-dideoxycytidine (ddC): relevance to HIV-dementia.
|
Exp Neurol
|
2006
|
0.90
|
|
58
|
Low molecular weight thiol amides attenuate MAPK activity and protect primary neurons from Abeta(1-42) toxicity.
|
Brain Res
|
2006
|
0.90
|
|
59
|
Long-term high-dose atorvastatin decreases brain oxidative and nitrosative stress in a preclinical model of Alzheimer disease: a novel mechanism of action.
|
Pharmacol Res
|
2010
|
0.90
|
|
60
|
Elevation of mitochondrial glutathione by gamma-glutamylcysteine ethyl ester protects mitochondria against peroxynitrite-induced oxidative stress.
|
J Neurosci Res
|
2003
|
0.89
|
|
61
|
Effects of apolipoprotein E on the human immunodeficiency virus protein Tat in neuronal cultures and synaptosomes.
|
J Neurosci Res
|
2004
|
0.89
|
|
62
|
Redox proteomics analyses of the influence of co-expression of wild-type or mutated LRRK2 and Tau on C. elegans protein expression and oxidative modification: relevance to Parkinson disease.
|
Antioxid Redox Signal
|
2012
|
0.88
|
|
63
|
Cell cycle proteins in brain in mild cognitive impairment: insights into progression to Alzheimer disease.
|
Neurotox Res
|
2011
|
0.87
|
|
64
|
Gamma-glutamylcysteine ethyl ester-induced up-regulation of glutathione protects neurons against Abeta(1-42)-mediated oxidative stress and neurotoxicity: implications for Alzheimer's disease.
|
J Neurosci Res
|
2005
|
0.87
|
|
65
|
Apolipoprotein A-I: insights from redox proteomics for its role in neurodegeneration.
|
Proteomics Clin Appl
|
2013
|
0.86
|
|
66
|
Methionine-35 of aβ(1-42): importance for oxidative stress in Alzheimer disease.
|
J Amino Acids
|
2011
|
0.85
|
|
67
|
Potential in vivo amelioration by N-acetyl-L-cysteine of oxidative stress in brain in human double mutant APP/PS-1 knock-in mice: toward therapeutic modulation of mild cognitive impairment.
|
J Neurosci Res
|
2010
|
0.85
|
|
68
|
Redox proteomics: understanding oxidative stress in the progression of age-related neurodegenerative disorders.
|
Expert Rev Proteomics
|
2008
|
0.84
|
|
69
|
Dietary vitamin D deficiency in rats from middle to old age leads to elevated tyrosine nitration and proteomics changes in levels of key proteins in brain: implications for low vitamin D-dependent age-related cognitive decline.
|
Free Radic Biol Med
|
2013
|
0.83
|
|
70
|
Gamma-glutamylcysteine ethyl ester protection of proteins from Abeta(1-42)-mediated oxidative stress in neuronal cell culture: a proteomics approach.
|
J Neurosci Res
|
2005
|
0.83
|
|
71
|
The wheat germ agglutinin-fractionated proteome of subjects with Alzheimer's disease and mild cognitive impairment hippocampus and inferior parietal lobule: Implications for disease pathogenesis and progression.
|
J Neurosci Res
|
2010
|
0.82
|
|
72
|
Proteomic analysis of brain proteins in APP/PS-1 human double mutant knock-in mice with increasing amyloid β-peptide deposition: insights into the effects of in vivo treatment with N-acetylcysteine as a potential therapeutic intervention in mild cognitive impairment and Alzheimer's disease.
|
Proteomics
|
2011
|
0.81
|
|
73
|
Lack of p53 decreases basal oxidative stress levels in the brain through upregulation of thioredoxin-1, biliverdin reductase-A, manganese superoxide dismutase, and nuclear factor kappa-B.
|
Antioxid Redox Signal
|
2012
|
0.81
|
|
74
|
Rat hippocampal responses up to 90 days after a single nanoceria dose extends a hierarchical oxidative stress model for nanoparticle toxicity.
|
Nanotoxicology
|
2013
|
0.80
|
|
75
|
Antisense directed against PS-1 gene decreases brain oxidative markers in aged senescence accelerated mice (SAMP8) and reverses learning and memory impairment: a proteomics study.
|
Free Radic Biol Med
|
2013
|
0.80
|
|
76
|
Rat brain pro-oxidant effects of peripherally administered 5 nm ceria 30 days after exposure.
|
Neurotoxicology
|
2012
|
0.80
|
|
77
|
Neurotoxicity and oxidative stress in D1M-substituted Alzheimer's A beta(1-42): relevance to N-terminal methionine chemistry in small model peptides.
|
Peptides
|
2004
|
0.79
|
|
78
|
In vivo protection of synaptosomes from oxidative stress mediated by Fe2+/H2O2 or 2,2-azobis-(2-amidinopropane) dihydrochloride by the glutathione mimetic tricyclodecan-9-yl-xanthogenate.
|
Free Radic Biol Med
|
2005
|
0.79
|
|
79
|
Sex differences in brain proteomes of neuron-specific STAT3-null mice after cerebral ischemia/reperfusion.
|
J Neurochem
|
2012
|
0.79
|
|
80
|
Lack of p53 affects the expression of several brain mitochondrial proteins: insights from proteomics into important pathways regulated by p53.
|
PLoS One
|
2012
|
0.79
|
|
81
|
Involvement of Stat3 in mouse brain development and sexual dimorphism: a proteomics approach.
|
Brain Res
|
2010
|
0.79
|
|
82
|
Quantitative expression proteomics and phosphoproteomics profile of brain from PINK1 knockout mice: insights into mechanisms of familial Parkinson's disease.
|
J Neurochem
|
2015
|
0.78
|
|
83
|
Antioxidant activity of X-34 in synaptosomal and neuronal systems.
|
Brain Res
|
2003
|
0.78
|
|
84
|
Difluoromethylornithine decreases long-lasting protein oxidation induced by neonatal ethanol exposure in the hippocampus of adolescent rats.
|
Alcohol Clin Exp Res
|
2007
|
0.77
|